查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
智慧医疗设备市场：2023年至2028年预测
市场调查报告书
商品编码
1410189

智慧医疗设备市场：2023年至2028年预测

Smart Medical Device Market - Forecasts from 2023 to 2028
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 129 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球智慧医疗设备市场预计将从2021年的1,363.95亿美元增至2028年的2,713.43亿美元，复合年增长率为10.33%。

全球智慧医疗设备市场的成长是由对无线和智慧型手机医疗设备的需求不断增长、设备技术的突破以及消费者健身意识的提高所推动的。此外，对感测器、心电图设备和带有健身追踪器的智慧型手錶等可穿戴医疗设备的需求正在增加，因为这些设备易于使用，不需要太多专业知识即可了解结果。因此，使用者可以监测自己的生命征象并了解自己的健康状况，而无需经常去诊所或医院。此外，预计老年人口将更容易采用这方面的智慧医疗设备。

此外，根据联合国2022年7月发布的《2022年世界人口展望》更新资料，欧洲及北美地区2022年人口老化程度最高，约占65岁及以上人口的19%。

慢性病增加

糖尿病、心血管疾病和呼吸系统疾病等慢性疾病的增加正在对全球智慧医疗设备市场产生重大影响。例如，根据 IDF 糖尿病地图集（2021 年），10.5% 的成年人（20-79 岁）患有糖尿病，而根据同一资讯来源，到2045 年，将有7 亿人（即八分之一的成年人）患有糖尿病近8300万人将患有糖尿病，增加了46%。医疗保健产业对治疗慢性病、为老年人提供高效的居家养老支持以及确保从住院护理到门诊居家医疗的无缝过渡有着浓厚的兴趣。智慧医疗设备透过正确遵循治疗计划和识别健康指标来帮助监控和管理解决方案。

印度智慧医疗设备市场预计将稳定成长。

在印度，智慧医疗设备产业近年来成长显着，已成为整个医疗保健产业的重要组成部分。医疗保健成本上升以及印度政府努力促进医疗保健技术的使用等因素正在推动对智慧医疗设备的需求，从而导致对更容易获得和更有效率的专业医疗技术的需求不断增加。我是。根据《2022-23 年经济调查》，印度医疗保健公共支出占 GDP 的 2.1%，而 2021 财年为 1.6%，2023 财年为 2.1%，2022 财年为 2.2%。

印度政府加大力度

印度政府的努力也在新兴市场的成长和开拓中发挥重要作用。印度製造倡议不仅增强了印度的製造能力，也为强大的本土数位基础设施铺平了道路，为印度人民带来了巨大利益。总理莫迪 (Narendra Modi) 在 2020 年第 84 个印度独立日宣布了国家数位健康使命 (NDHM)，旨在建立一个生态系统，在印度各地提供更好的医疗保健服务。

这种现有的数位基础设施可以有效地识别和连接个人，并透过数位手段简化他们的日常生活，包括Aadhaar唯一身分（UID）、JAM三位一体（Jan Dhan-Aadhaar-Mobile）、统一支付介面（UPI ）等重要组件。这强大的数位基础为 NDHM 提供了坚实的起点，促进数位管理医疗服务的进一步发展和增强。

市场主要发展

  • 2022年11月，美敦力在美国推出「美敦力扩展融合套装」。

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表

第二章调查方法

  • 调查资料
  • 先决条件

第三章执行摘要

  • 研究亮点

第四章市场动态

  • 市场驱动因素
  • 市场抑制因素
  • 波特五力分析
  • 产业价值链分析

第五章全球智慧医疗设备市场：按类型

  • 介绍
  • 诊断和监测设备
  • 治疗设备

第六章全球智慧医疗设备市场：依应用分类

  • 介绍
  • 心血管
  • 神经病学
  • 呼吸系统
  • 其他的

第七章全球智慧医疗设备市场：依最终用户分类

  • 介绍
  • 医院和诊所
  • 门诊治疗中心
  • 家庭护理设置

第八章全球智慧医疗设备市场：按地区

  • 介绍
  • 北美洲
    • 按类型
    • 按用途
    • 按最终用户
    • 按国家/地区
  • 南美洲
    • 按类型
    • 按用途
    • 按最终用户
    • 按国家/地区
  • 欧洲
    • 按类型
    • 按用途
    • 按最终用户
    • 按国家/地区
  • 中东/非洲
    • 按类型
    • 按用途
    • 按最终用户
    • 按国家/地区
  • 亚太地区
    • 按类型
    • 按用途
    • 按最终用户
    • 按国家/地区

第九章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议与合作
  • 供应商竞争力指数

第十章 公司简介

  • Boston Scientific Corporation
  • ViVO Smart Medical Devices Ltd
  • Dexcom Inc
  • Abbott Laboratories
  • Medtronic Plc.
  • NeuroMetrix, Inc.
  • Omron Healthcare, Inc.
简介目录
Product Code: KSI061611834

The global smart medical devices market is estimated to grow at a CAGR of 10.33% reaching US$271.343 billion in 2028 from US$136.395 billion in 2021.

The global smart medical devices market growth is being propelled by the increasing demand for wireless and smartphone-compatible medical equipment, device technology breakthroughs, and increased consumer awareness of fitness. Moreover, as these devices are simple to use and don't require a lot of specialized knowledge to understand the results, demand for wearable medical devices has increased like sensors, ECG devices, and smartwatches with fitness trackers. As a result, the user can monitor their vital signs to maintain tabs on their health status without having to often visit clinics or hospitals. Additionally, the elderly population is anticipated to adopt this aspect of smart medical devices more readily.

Furthermore, according to data updated by the UN in its World Population Prospectus 2022, which was published in July 2022, Europe and Northern America had the oldest populations in 2022, with nearly 19% of the population being 65 years of age or older.

Rising prevalence of chronic diseases

The rise in the prevalence of chronic diseases including diabetes, cardiovascular, and respiratory problems has a big impact on the global smart medical devices market. For instance, 10.5% of adults (20-79 years) have diabetes, according to the IDF Diabetes Atlas (2021), and as per the same source nearly 783 million adults, or one in eight, would have diabetes by 2045, a 46% rise. The healthcare sector is highly concerned with treating chronic illnesses, offering efficient aging-in-place support to an older population, and guaranteeing a seamless transition from inpatient hospital care to outpatient home care. By properly following the treatment plans and recognizing health metrics, smart medical devices assist in monitoring and managing solutions.

It is projected that the smart medical devices market in India will grow steadily.

India has been experiencing significant growth in the smart medical devices industry in recent years, making it a significant segment within the broader healthcare industry. Factors such as increasing healthcare expenditure followed by the Indian governmental initiatives to promote the use of technology in healthcare are driving the demand for smart medical devices, which in turn drives the need for specialized medical technologies making them more accessible and efficient. According to the Economic Survey 2022-23, India's public expenditure on healthcare touched 2.1 % of GDP in FY23 and 2.2% in FY22, against 1.6% in FY21.

Increasing Government Initiatives in India

Indian government initiatives are also playing a significant role in the growth and development of the smart medical devices market in the country. The Make in India initiative has not only bolstered the country's manufacturing capabilities but has also paved the way for a robust and domestically developed digital infrastructure, greatly benefiting the citizens. In a bid to establish an ecosystem that delivers improved healthcare services across India, Prime Minister Narendra Modi announced the National Digital Health Mission (NDHM) on India's 84th Independence Day in 2020.

This existing digital infrastructure, which efficiently identifies and connects individuals and simplifies their daily lives through digital means, includes key components like the Aadhaar Unique Identity (UID), the JAM trinity (Jan Dhan-Aadhaar-Mobile), and the Unified Payments Interface (UPI). This strong digital foundation provides a solid launching pad for NDHM, facilitating further development and enhancement of healthcare services through digital management.

Market Key Developments

  • In November 2022, Medtronic launched the "Medtronic Extended Fusion Set" in the US which uses advanced materials for reducing insulin preservative loss and thereby maintaining insulin flow.

Segmentation:

By Type

  • Diagnostic and Monitoring Devices
  • Therapeutic Devices

By Application

  • Cardiovascular
  • Neurology
  • Respiratory
  • Others

By End-User

  • Hospitals and Clinics
  • Ambulatory Care Centers
  • Home Care Settings

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

  • 2.1. Research Data
  • 2.2. Assumptions

3. EXECUTIVE SUMMARY

  • 3.1. Research Highlights

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Force Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. GLOBAL SMART MEDICAL DEVICES MARKET, BY TYPE

  • 5.1. Introduction
  • 5.2. Diagnostic and Monitoring Devices
  • 5.3. Therapeutic Devices

6. GLOBAL SMART MEDICAL DEVICES MARKET, BY APPLICATION

  • 6.1. Introduction
  • 6.2. Cardiovascular
  • 6.3. Neurology
  • 6.4. Respiratory
  • 6.5. Others

7. GLOBAL SMART MEDICAL DEVICES MARKET, BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals and Clinics
  • 7.3. Ambulatory Care Centers
  • 7.4. Home Care Settings

8. GLOBAL SMART MEDICAL DEVICES MARKET, BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By End-User
    • 8.2.4. By Country
    • 8.2.4.1. USA
    • 8.2.4.2. Canada
    • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Type
    • 8.3.2. By Application
    • 8.3.3. By End-User
    • 8.3.4. By Country
    • 8.3.4.1. Brazil
    • 8.3.4.2. Argentina
    • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Type
    • 8.4.2. By Application
    • 8.4.3. By End-User
    • 8.4.4. By Country
    • 8.4.4.1. UK
    • 8.4.4.2. Germany
    • 8.4.4.3. France
    • 8.4.4.4. Spain
    • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Type
    • 8.5.2. By Application
    • 8.5.3. By End-User
    • 8.5.4. By Country
    • 8.5.4.1. Saudi Arabia
    • 8.5.4.2. Israel
    • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Type
    • 8.6.2. By Application
    • 8.6.3. By End-User
    • 8.6.4. By Country
    • 8.6.4.1. Japan
    • 8.6.4.2. China
    • 8.6.4.3. India
    • 8.6.4.4. South Korea
    • 8.6.4.5. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisition, Agreements and Collaboration
  • 9.4. Vendor Competitiveness Index

10. COMPANY PROFILES

  • 10.1. Boston Scientific Corporation
  • 10.2. ViVO Smart Medical Devices Ltd
  • 10.3. Dexcom Inc
  • 10.4. Abbott Laboratories
  • 10.5. Medtronic Plc.
  • 10.6. NeuroMetrix, Inc.
  • 10.7. Omron Healthcare, Inc.